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Cholesterol 7a-hydroxylase (7a-hydroxylase) is the rate-limiting enzyme in bile acid biosynthesis. It is
subject to a feedback control, whereby high levels of bile acids suppress its activity, and cholesterol exerts a
positive control. It has been suggested that posttranscriptional control plays a major part in that regulation.
We have studied the mechanisms by which cholesterol and bile acids regulate expression of the 7a-hydroxylase
gene and found it to be solely at the transcriptional level by using two different approaches. First, using a tissue
culture system, we localized a liver-specific enhancer located 7 kb upstream of the transcriptional initiation
site. We also showed that low-density lipoprotein mediates transcriptional activation of chimeric genes,
containing either the 7a-hydroxylase or the albumin enhancer in front of the 7a-hydroxylase proximal
promoter, to the same extent as the in vivo cholesterol-mediated regulation of 7a-hydroxylase mRNA. In a
second approach, using transgenic mice, we have found that expression of an albumin enhancer-7a-
hydroxylase-IacZ fusion gene is restricted to the liver and is regulated by cholesterol and bile acids in a manner
quantitatively similar to that of the endogenous gene. We also found, that a liver-specific enhancer is necessary
for expression of the rat 7a-hydroxylase gene, in agreement with the tissue culture experiments. Together, these
results demonstrate that cholesterol and bile acids regulate the expression of the 7a-hydroxylase gene solely
at the transcriptional level.
Cholesterol homeostasis is maintained through the regula-
tion of three metabolic pathways. Two pathways function in
the supply of cholesterol to cells. These include an endogenous
biosynthetic pathway in which cholesterol is synthesized from
acetate precursors and an exogenous pathway in which the
low-density lipoprotein (LDL) receptor internalizes cholester-
ol-carrying lipoprotein particles from the blood (20). A third
pathway functions in the catabolism of cholesterol and involves
its conversion to bile acids. Improper regulation of this path-
way has pathological implications because the major pathway
for the catabolism and excretion of cholesterol in mammals is
the formation of bile acids. The rate of elimination of choles-
terol is a critical factor in diseases such as atherosclerosis,
gallstone disease, and some lipid storage diseases (5, 11, 13).
The initial and rate-limiting step in this pathway is the hydroxy-
lation of cholesterol at position 7 and is catalyzed by the
enzyme cholesterol 7a-hydroxylase (7oa-hydroxylase) (choles-
terol 7a-monooxygenase; EC 1.14.13.17), a microsomal cyto-
chrome P450 (35). This enzyme is subject to a feedback
control, whereby high levels of bile acids returning to the liver
via the enterohepatic circulation suppress its activity. Choles-
terol, the substrate of the enzyme, exerts a positive control.
The rat and human 7ot-hydroxylase cDNAs have been
isolated by several groups (7, 26, 30, 37, 38). The availability of
these molecular probes has facilitated studies directed towards
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understanding the molecular mechanisms that regulate bile
acid synthesis. For example, Jelinek et al. have shown that the
7a-hydroxylase gene is expressed only in liver (26), as ex-
pected, since bile acids are synthesized only in that organ (35).
Also, the activity of 7a-hydroxylase exhibits a circadian rhythm
in rats, with a maximum at midnight and a minimum during the
daytime (35). This diurnal variation of enzyme activity is due to
changes in the protein and mRNA levels (39) and appears to
be due, at least in part, to variable levels of glucocorticoids
(32).
Specific dietary manipulations have been shown to alter
7ot-hydroxylase protein levels, enzyme activity, and mRNA
levels. Cholestyramine, a resin that binds bile acids, thus
reducing their levels in the liver, and cholesterol feeding of rats
effectively up-regulates 7a-hydroxylase protein levels and en-
zyme activity by increasing the amount of 7a-hydroxylase
mRNA about twofold (26, 30, 39, 53). In addition, 7a-
hydroxylase mRNA and protein levels decrease (5- to 10-fold)
when rats are fed bile acids (26).
Different approaches have been used to study the molecular
mechanism(s) involved in the bile acid- and cholesterol-medi-
ated regulation of the 7a-hydroxylase gene. It has been pro-
posed that transcriptional regulation plays a role by analogy
with other systems involved in cholesterol homeostasis (26, 33,
46, 52). Studies in tissue culture systems have been difficult
because of the lack of appropriate cell lines with which
transcriptional regulation could be studied. Recently, chimeric
genes containing fragments of the 5'-flanking region of the
human 7a-hydroxylase gene have been expressed in HepG2
cells, but it is not known whether they are regulated by
cholesterol and/or bile acids (33). Bile acid-mediated regula-
tion of 7a-hydroxylase mRNA and transcription has been
shown in isolated primary rat hepatocytes (24, 52), although
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the extent of regulation (2-fold) differs from the regulation of
mRNA levels in the entire animal (5- to 10-fold) (26,53). It has
been suggested that posttranscriptional control plays a major
part in that regulation as shown by nuclear run-on assays (52)
and by the discrepancy between the bile acid-mediated regu-
lation of 7a-hydroxylase mRNA in hepatocytes in culture
(ninefold) compared with the twofold decrease in transcription
as quantified by run-on or by the suppression of a chloram-
phenicol acetyltransferase (CAT) activity directed by promoter
constructs containing up to 3.6 kb of 7a-hydroxylase upstream
sequences.
Two methods are currently available to test for regulated
expression of the transcription of cloned genes. One approach
is to introduce a purified gene into cells in culture by transfec-
tion. Regulation is measured by the differential expression of a
gene in an appropriate cell line upon addition of the effector.
Major advantages of this method are the relative ease in
testing multiple genes or altered gene constructs and the speed
of the assay. It is impractical, however, when cell-specific
functions ought to be studied, since cells in culture tend to
express all transfected eukaryotic genes at a low basal level
regardless of cell specificity. Similarly, conditions such as
cholesterol homeostasis require whole animal models to study
the complex interaction of whole organ systems. The other
approach of choice is to introduce cloned genes into all cells of
an animal by microinjection into fertilized eggs to create
transgenic animals (41). A major advantage of this method is
the ability to assay for expression in many tissues of an animal.
It also provides a more physiological system for studying
tissue-specific and developmentally regulated genetic elements
(42). The limitation of transgenic technologies is the length of
time required for the production and generation of several
lines of transgenic animals containing a single gene construct.
In the present study, we used both approaches to investigate
the regulation of the expression of the 7a-hydroxylase gene.
First, we used a conditionally transformed hepatocyte cell line,
H2.35 (56), to transfect chimeric genes containing different
portions of the 5'-flanking region of the rat 7ot-hydroxylase
gene. This system allowed us to localize a liver-specific en-
hancer located 7 kb upstream of the transcriptional initiation
site. We have also shown that LDL mediates transcriptional
activation of chimeric genes containing either the 7ot-hydrox-
ylase or the albumin enhancer in front of the 7ot-hydroxylase
promoter in differentiated liver cells, to the same extent as the
in vivo cholesterol-mediated regulation of 7a.-hydroxylase
mRNA. However, bile acids only partially (twofold) regulated
rat 7a-hydroxylase promoter activity in that tissue culture
system. Thus, we used transgenic mice to study that regulation,
and we showed that mice harboring a chimeric gene carrying
the 7ao-hydroxylase 5'-flanking region with the albumin en-
hancer expressed the reporter gene whereas a fusion gene
containing the same 7a-hydroxylase proximal promoter but
without enhancer did not show expression. This analysis sup-
ported our tissue culture experiments which indicate that
either the 7a-hydroxylase enhancer or the albumin enhancer is
necessary for transcription of the 7o-hydroxylase promoter
(see Fig. 1, 2, and 6). More importantly, expression of the
transgene is regulated by cholesterol and bile acids in a manner
similar to the expression of the endogenous gene. These results
demonstrate that cholesterol and bile acids regulate the ex-
pression of the 7a-hydroxylase gene solely at the transcrip-
tional level. The systems presented in this article provide
experimental approaches to study cholesterol- and bile acid-
mediated regulation of 7ot-hydroxylase transcription.
MATERIALS AND METHODS
Materials. 32P-labeled nucleotides, 35S-dATP and [14C]
chloramphenicol were purchased from Du Pont New England
Nuclear, Boston, Mass. Restriction enzymes and other en-
zymes used in DNA cloning and DNA sequencing were
obtained from commercial sources and used according to
recommendations of the manufacturer. XGEM-11 and pCAT
(a promoterless plasmid containing the coding region of the
bacterial CAT gene and the simian virus 40 [SV40] t intron and
polyadenylation signals) (45) were obtained from Promega,
Madison, Wis. Oligonucleotides were synthesized by the phos-
phoramidite method on an Applied Biosystems model 380A
DNA synthesizer. G418 sulfate (Geneticin) was purchased
from GIBCO Laboratories. pSV3-neo, a plasmid that confers
resistance to the neomycin (Neo) analog G418, was obtained
from Bethesda Research Laboratories. Mouse chow was ob-
tained from Agway Inc. (Syracuse, N.Y.). Cholesterol was
purchased from ICN Biochemicals (Cleveland, Ohio). Colesti-
pol (Colestid) was purchased from The Upjohn Co. (Kalama-
zoo, Mich.); cholic acid and chenodeoxycholic acid were
obtained from Sigma.
General methods. Restriction enzyme digestions, agarose
gel electrophoresis, and DNA and RNA blotting and hybrid-
ization were carried out by standard procedures as described
by Sambrook et al. (48). DNA probes were 32p labeled by the
method of Church and Gilbert (9). DNA sequencing was done
by the dideoxy chain termination method of Sanger et al. (49)
with either the M13 universal sequencing primer or specific
oligonucleotides, after subcloning into bacteriophage M13
vectors (48). In certain GC-rich regions, 20% formamide was
used in the sequencing gels (12). Both strands were sequenced
at least once. Human LDL and lipoprotein-deficient fetal calf
serum were prepared by ultracentrifugation (18). Protein
content was measured by the method of Bradford (2).
Cloning of the rat 7a-hydroxylase gene. Rat liver DNA was
prepared as described elsewhere (48). After partial Sau3AI
digestion, fragments ranging in size between 15 and 25 kb were
purified and ligated to the BamHI arms of the cloning vector
XGEM-11. After in vitro packaging of the recombinant mole-
cules into infectious phage particles, clones were screened for
inserts containing 7ot-hydroxylase sequences by in situ hybrid-
ization (48) using as a probe an oligonucleotide complemen-
tary to nucleotides +86 to + 125, which corresponds to the
beginning of the coding region of the published rat 7a-
hydroxylase cDNA sequence (37). Two clones, XR7a-1 and
XR7oa-2, were identified out of 3 x 105 recombinants. For
more detailed analysis of X clones, subgenomic fragments were
generated by digestion with EcoRI, BamHI, and PstI and
subcloned into plasmid vectors. The transcriptional initiation
site was determined by primer extension and S1 nuclease
analysis and coincided, essentially, with the position described
by Jelinek et al. (27).
Plasmid constructions. Plasmid pR7oaCAT-1 was con-
structed by insertion of a 4-kb PstI fragment, excised from
XR7ot-1, which spans from 1.6 kb upstream of the transcrip-
tional initiation site to the second intron in the 7ax-hydroxylase
gene. To delete the first two exons from this construct, we
introduced a Sall site at position +59 (Fig. 1) by PCR
techniques (47) and ligated it to the SalI site in the polylinker
of pCAT, upstream of the CAT gene, to generate pR7aCAT-3.
pR7aCAT-9 and pR7aCAT-8 were made by inserting the
XbaI-PstI fragments (-7455 to - 1671 and -6265 to - 1671,
respectively) into the PstI site of pR7aCAT-3. pR7otCAT-10
was created by deletion of the XbaI-SphI fragment in
pR7oLCAT-8 and recircularization. pR7aCAT-5 was made
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FIG. 1. Promoter activity of 5' deletion mutants of the rat 7a-hydroxylase promoter in H2.35 cells. The DNA fragment (thin solid bar) from
the 5'-flanking region of the rat 7oa-hydroxylase gene is shown with the restriction sites used for plasmid constructoin (see Materials and Methods).
The CAT coding sequence is denoted by the hatched bar. The putative TATA box and a potential TGT3-HNF-3 site are indicated. A scheme of
the different chimeric genes used is shown. H2.35 cells were stably transfected with the indicated plasmid as explained in Materials and Methods.
After selection of G418 resistant colonies, cells were cultured under differentiating or nondifferentiating conditions as described in Materials and
Methods. Relative transcription was determined by measuring CAT activity with amounts of extracts that contained the same amount of
i-galactosidase (e-gal) activity. The data are expressed as percentages of the activity produced by the construct containing the longest promoter
fragment, pR7ot-CAT-9, under dedifferentiating conditions and represent the averages of seven experiments with two different transfections ±
standard errors of the mean.
from pR7aCAT-3 by Hindlll digestion and recircularization.
p7cE-R7acCAT-5 was made by blunt-end ligation of the XbaI-
XbaI fragment (-7454 to -6265 from the 7a-hydroxylase
transcription initiation site) into the HindlIl site of
pR7aCAT-5. pAE-R7aCAT-5 was prepared by blunt-end
ligation of the NheI-BamHI fragment (- 10400 to -8500 from
the mouse albumin gene [43]) excised from pAN/T2-NB' (a
plasmid that contains the mouse albumin enhancer and pro-
moter, kindly provided by K. S. Zaret, Brown University) into
the Hindlll site of pR7aCAT-5. pGal, a promoterless plasmid
containing the bacterial lacZ gene, was constructed by replac-
ing the bacterial CAT coding region from pCAT by the lacZ
gene obtained by Dral digestion of pNK 1915 (a gift from P.
Dobner, University of Massachusetts Medical School).
pR7aGal-3 was made by ligation of a 4.1-kb BamHI-SalI
fragment containing the lacZ gene and the SV40 t intron and
poly(A) addition site from pGal to the 4.4-kb BamHI-SalI
backbone from pR7aCAT-3. pAE-7aGal-3 was prepared by
blunt-end ligation of the NheI-BamHI fragment into the PstI
site of the plasmid pR7acGal-3. Plasmid DNA was purified by
two CsCl gradients, and the integrity of the DNA was verified
by sequencing when necessary.
Cell culture and transfection experiments. H2.35 cells (56)
(a temperature-sensitive, SV40-transformed mouse hepatocyte
cell line kindly provided by K. S. Zaret) were cultured as
described by Zaret et al. (56). Briefly, cells were maintained in
basal medium (Dulbelcco's modified eagle medium supple-
mented with 4% fetal calf serum, 0.2 ,uM dexamethasone, and
antibiotics) at 33°C in a humidified atmosphere of 5% CO2.
Cells were cotransfected by the calcium phosphate method as
modified by Chen and Okayama (6), using 15 pug of the test
plasmid and 1 ,ug of pSV3-neo. To normalize for efficiency of
transfection, a reference plasmid (pSV-gal; 4 ,ug) containing
the bacterial lacZ gene under the control of the SV40 early
promoter was cotransfected with the test plasmid. Selection
with G418 (1 mg/ml) was maintained for 2 weeks. Resistant
colonies were pooled (150 to 300 colonies per transfection)
and expanded in mass culture in the presence of 1 mg of G418
per ml.
For each experiment, 100-mm-diameter plastic dishes were
seeded on day 0 at 106 cells per dish in 8 ml of basal medium
and incubated at the permissive temperature for SV40, 33°C
(dedifferentiating conditions). For differentiating conditions,
100-mm-diameter dishes containing 4 ml of a 1.35-mg/ml gel of
rat type I collagen prepared exactly as described by Zaret et al.
(56) were seeded with 2 x 106 cells per dish in 8 ml of basal
medium supplemented with 10% fetal calf serum. After the
cells on collagen were cultured at the nonpermissive temper-
ature (39°C) for 3 to 5 h, the medium was replaced by
serum-free medium (56) and maintained at 39°C. On day 2,
cells were refed with either basal medium or serum-free
medium and harvested by scraping (plastic dishes) or by a brief
collagenase digestion (collagen plates) on day 3. Cells were
lysed by three cycles of freeze-thawing, and ,-galactosidase
activity was determined as described by Sambrook et al. (48)
with o-nitrophenyl-fi-D-galactopyranoside as a substrate. One
unit of ,-galactosidase activity is defined as the amount of
enzyme that transforms 1 ,umol of substrate per min at 37°C.
CAT activities were measured by the method of Gorman et al.
(21), after the cell extracts were incubated at 65°C for 5 min.
One unit of CAT activity is defined as the amount of enzyme
which transforms 1 nmol of chloramphenicol into its acetylated
products per min at 37°C. All assays were linear regarding time
of incubation and concentration of protein.
DNA preparation for microinjection and generation of
transgenic mice. For microinjection, the pR7aCAT-3 fusion
gene (see Fig. 5) was prepared by PstI-BamHI digestion of
pR7aCAT-3 (3.4 kb). The AE-7aGal-3 fusion gene (7.8 kb)
(see Fig. 5) was prepared by BamHI complete digestion and
SphI partial digestion of pAE-7aGal-3. DNA fragments were
Xba l Xba l
l l
IGC,,AAACAI
HNF-3
Sph I
-3576
-7454
Plastic - 33°C Collagen - 39°C
De-differentiated Differentiated
(CAT4I-gal) (CAT43-gal)
100 410+114
26t5 32t5
29t4 42t7
21t4 23t4
31t6 21t4
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isolated by agarose gel electrophoresis and electroelution and
further purified with Elutip minicolumns (Schleicher &
Schuell). Linearized DNA was dissolved in 5 mM Tris (pH
7.4)-O.1 mM EDTA at a final concentration of 1 pLg/ml. Two to
five picoliters was microinjected into the male pronucleus of
fertilized B6SJLF1/J embryos (Jackson Laboratories, Bar Har-
bor, Maine) by standard techniques and transferred into the
oviducts of pseudopregnant CD1 foster mothers (23). Founder
males were mated to female wild-type C57BL/6 mice.
DNA analysis and estimation of gene copy number. To
identify transgenic founder mice, genomic DNA was isolated
from the tails of 4- to 5-week-old pups, digested with EcoRI
(for R7otCAT-3) or with Avall (for AE-R7oxGal-3), and sub-
jected to Southern blot analysis. Hybridization was done with a
32P-labeled single-stranded M13 probe (9) prepared from the
coding region of the CAT gene or from a 419-bp fragment of
the 7x-hydroxylase-lacZ fusion gene (-267 to +152). The
number of copies of inserted DNA per genome was estimated
by using a calibration curve of pR7otCAT-3 or pAE-7otGal-3
DNA, processed under the same conditions. Further genera-
tions of transgenic mice were detected by PCR techniques
using blood samples (29) to screen a large number of offspring.
A 465-bp fragment of the 5' region of the lacZ gene was
amplified (47).
Feeding of mice. Transgenic mice were kept under a 12-h
light/12-h dark cycle. Male and female mice, 6 to 8 weeks old,
were fed as follows: (i) regular chow diet (normal diet), (ii)
normal diet supplemented with 2% (wt/wt) cholesterol for 14
days, (iii) normal diet supplemented with 5% (wt/wt) colestipol
for 5 days, (iv) normal diet supplemented with 0.5% (wt/wt)
cholic acid for 5 days, or (v) normal diet supplemented with
0.5% (wt/wt) chenodeoxycholic acid for 5 days. Animals were
killed between the 6th and 8th of the dark period.
Preparation of tissue extracts and assay of ,I-galactosidase
activity. Mouse tissues (0.5 g) were homogenized in a Dounce
homogenizer on ice, with 5 ml of 40 mM Tris-HCl (pH 7.4)-i
mM EDTA-500 mM sucrose-150 mM NaCl-10 mM dithio-
threitol. The lysates were cleared by centrifugation at 10,000 x
g for 30 min at 4°C. The soluble fraction was purified by
ultracentrifugation at 100,000 x g for 90 min at 4°C and used
to quantify P-galactosidase or CAT activity.
RNA purification and analysis. Total cellular RNA was
isolated from tissue-cultured cells by guanidinium thiocyanate
extraction followed by centrifugation through a cesium chlo-
ride cushion (8). Primer extension analysis of Neo mRNA was
performed with 15 fmol of a 40-nucleotide synthetic DNA
primer complementary to nucleotides +261 to +300 of Neo
RNA (1). To initiate primer extension, 100 U of Moloney
murine leukemia virus reverse transcriptase was added to the
mixture and incubated for 1 h at 37°C in the presence of
deoxynucleotides as described elsewhere (15). Si nuclease
analysis of the 5' end of the 7o-hydroxylase-CAT mRNA was
performed essentially as described elsewhere (15), except that
the annealing temperature was 44°C, by using a single-stranded
probe that spans from position -39 in the 7a-hydroxylase
5'-flanking region to the EcoRI site within the CAT coding
region.
Total RNA was purified from mouse liver by guanidinium
thiocyanate homogenization followed by centrifugation
through a cesium chloride cushion (8). Equal amounts of the
individual RNA samples (five to seven per group) were pooled.
Poly(A)+ RNA was isolated from those pools by using a Mini
Ribo Sep Ultra mRNA isolation kit (Collaborative Biomedical
Products, Bedford, Mass.). RNA slot blotting and hybridiza-
tion were carried out by standard procedures (48). Three
different M13 single-stranded probes, prepared as described by
Church and Gilbert (9), were used. The ,-galactosidase probe
was a 419-bp fragment (-267 to + 152) from the 7a-hydroxy-
lase-lacZ fusion gene; the 7o-hydroxylase probe contained a
1.1-kb BamHI fragment from the 5' end of the rat 7ot-
hydroxylase cDNA. As a control, we used a hamster albumin
cDNA probe (16). 7ox-Hydroxylase and albumin hybridizations
were done in 35% (vol/vol) formamide solution (48) containing
32P-labeled probes at 2 x 106 cpm/ml. After overnight hybrid-
ization at 42°C, membranes were washed in 4 x SSC (1 x SSC
is 150 mM NaCl plus 15 mM sodium citrate)-0.2% sodium
dodecyl sulfate (SDS) at 55°C. Hybridization with the f-galac-
tosidase probe was carried out in 50% (vol/vol) formamide
solution, and the membranes were washed in 0.5 x SSC-0.2%
SDS at 65°C.
RESULTS
Localization of a liver-specific enhancer in the rat choles-
terol 7ei-hydroxylase gene. Figure 1 shows the 5'-flanking
region of the rat 7o--hydroxylase gene and the structures of five
7ox-hydroxylase-CAT chimeric genes which were used to local-
ize DNA sequences necessary for the transcription of the
7cx-hydroxylase gene in a liver-specific manner. Nucleotide + 1
corresponds to the transcription initiation site as defined by
primer extension and S1 nuclease analysis of the rat mRNA
(data not shown) and differs by 1 nucleotide from the site
described by Jelinek and Russell (27). Five chimeric genes
were created by placing different parts of the rat 7a-hydroxy-
lase 5'-flanking region in front of the coding region of the CAT
gene. As a recipient cell line, we used a temperature-sensitive,
SV40-transformed mouse hepatocyte cell line, H2.35 (56), that
has been shown to be extremely useful in the study of
liver-specific functions. When H2.35 cells are cultured under
the dedifferentiating conditions (see Materials and Methods),
the cells assume a flat structure and transcribe liver-specific
genes such as albumin at very low rates. When cultured at the
differentiating conditions, the cells exhibit a cuboidal structure,
and the transcription of a subset of liver-specific genes is
increased selectively (31, 56).
As shown in Fig. 1, when stably transfected H2.35 cells were
cultured under dedifferentiating conditions, plasmid pR7ot
CAT-9 consistently produced the highest ratio of CAT/1-
galactosidase activity. Most importantly, when cells were cul-
tured under differentiating conditions CAT activity was in-
creased (an average of fourfold) only in cells transfected with
pR7aCAT-9. CAT activity for all other cell lines did not show
any noticeable differences between the two culture conditions.
These results indicated that the fragment -7454 to -6265
located at the very 5' end of pR7oLCAT-9, which is deleted in
pR7otCAT-8, acts as a liver-specific enhancer of 7ox-hydroxy-
lase transcription.
To study whether the DNA sequences located between
- 6265 and -342 were in fact dispensable for 7cx-hydroxylase
transcription as suggested by the experiments in Fig. 1, we
deleted these sequences, placing the 7ot-hydroxylase enhancer
in front of the promoter fragment in pR7otCAT-5, to generate
p7oaE-R7oLCAT-5 (Fig. 2A). When H2.35 cells transfected with
this chimeric gene were cultured under dedifferentiating and
differentiating conditions, a level of induction of CAT activity
(Fig. 2C), upon hepatocyte differentiation, comparable to that
with cells transfected with pR7oLCAT-9 was observed. The
ratios of CAT/,-galactosidase activities in cells transfected
with pR7oaCAT-9 or p7otE-R7otCAT-5 were equivalent. p7oxE-
R7oaCAT-5 has the 7ox-hydroxylase enhancer in the reverse
orientation, and similar induction under differentiating condi-
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FIG. 2. Promoter activity and S1 nuclease mapping of the transcription initiation site of the 7ot-hydroxylase promoter-CAT chimeric gene in
H2.35 cells transfected with p7oaE-R7otCAT-5. (A) Scheme of the internally deleted p7aE-R7ctCAT-5 construct containing the rat 7ot-hydroxylase
enhancer (in the reverse orientation) in front of 342 bp of the proximal promoter. H2.35 cells were transfected and cultured as explained in
Materials and Methods, in duplicate dishes under dedifferentiating and differentiating conditions. One set of dishes was processed for CAT activity,
and another was used to prepare RNA. (B) RNAs from dedifferentiated (lane 4) and differentiated (lane 5) cells and tRNA as a control were used
to quantify 7aCAT mRNA by S1 nuclease analysis, with Neo mRNA as a control, as explained in Materials and Methods. Standards shown on
the left in nucleotides (nt) were derived from an MspI digest of pBR322. (C) Relative values of CAT specific activity and CAT mRNA normalized
to Neo mRNA. A Betagen analyzer was used to directly measure counts per minute per band.
tions was observed when the enhancer was placed in the same
orientation as the endogenous gene (data not shown).
To determine whether the increase in CAT activity, upon
hepatocyte differentiation, is a reflection of the amount of
CAT mRNA and whether the initiation site used in the
p7acE-R7aCAT-5-transfected cells corresponded to the initia-
tion site used by the endogenous rat 7oa-hydroxylase mRNA,
we performed Si nuclease analysis with RNAs isolated from
those cells grown under both conditions. As a probe, we used
a single-stranded DNA fragment that encompasses the tran-
scriptional initiation site, and as a control, we quantified Neo
mRNA by the primer extension technique. Figure 2B shows
that the amount of CAT mRNA increased approximately
threefold upon differentiation (lanes 4 and 5), and the length
of the protected fragments indicated that the hybrid mRNA
was initiated at the appropriate position.
Nucleotide sequence of the 7a-hydroxylase gene enhancer.
Figure 3A shows the nucleotide sequence of the 7oa-hydroxy-
lase enhancer region (-7454 to -6264 from the transcrip-
tional initiation site). Examination of the enhancer region by
A
Xba I
CAT
B
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A XbaI
-7454 iCAATTTGGAAGAAACTTCAAAATCAT CATACTGAGGCAGTGATACCTTTGAATAAG TTTGGCCCCCATATAATCCCATGTTTCAAT
-7364 GCTTCCTTACTGAAGGAGTTGTGGCTTTGC TGGAGAAAGTGTGTCACTGTGTGGGTGGGC TTTGAGGTCTCAATATGATGAGGCTTTGCC
-7274 CAGTGTGGAAGAATCTCCTTCTGCTGCCTT TAGATCAAGATGTAGAACTCTACTCTATCT CCGGGGCCATGTAGACCTGTATATGCTGTC
-7184 ATGCTTCCTGCCATGATGTTAATGGACATG CTTCTGAGGCTGTAAGCAGCCAAATTTCTT ATAAGACTTGCCTTGGTTATGATGTCTCTT
-7094 CACGGCAATGAAACCCAAACTAAGACATGC CTACTACTAAAGTCAAAGATCTTCTATATG AGACCCATTCCAAACCAGTGTCCCTAGTGC
-7004 CCATGGATTGAGAAATCTCCCATAAACAAA GTTAGCAATAATAACCATAATAGCCTTATA CCCCTGACAAGCAGGACTTATCCCACCAAT
-6914 AGAAATAGCCTAGCAAGCAAAGGAAACAAT GAAATACTTCCCAGCAGCATAGAGAAACAC AAAGAATCTCACTGACAAAGAAAAACAACA
FP I
-6824 GATCAAAAATCTCTCCCCCTTCCATGAGAA ACACTCTACAAGTAAGAAATCAATATCTAC AAAGAAGACTTCAAGATACCACAGCTGATA
FP II FP III
-6734 CACTTAATGAAATAAGTGACTGAAATATTT TCTCCTAGACAAGGATCTCTGTCTTCACTA CTTGTTCCACATTTTACTAATGGCTGTATC
-6644 TGGTGCAGCTAGACCAGAGAAATAAAAGGA GAAAATAGTCTCAAAGAATAAATGAGCCTG TTTATTAAAAGACCTGAAGAATCTACACAG
-6554 TAGTATTGAGAGCTACCTTCTTCAGAGTTA GGGGATGCAAGGCGAAATTTCAAAAATCCA GTCTAGCTTTATAATTTCTGAACAGTAGCG
FP IV FP V
r **I
-6464 ATGAACACTGTAACTGGAGTTATGAAACAA CTCCGTGTGTGAAAACATAAAGTCCTTAGA AATAAGTGCAACAAACTATACAATAAAAGC
FP VI
-6374 GACAAAACATTATTGAAAAAAAAACTACAG AAGACCTCAGCAAACAGAAACTCATGTTCC CCAATCAAAAGGAACCTAATTCTGATGGAC
* I
FP VII
-6284 TGTCCTCTCCTCAAATTGA A AAGA AATTAGATGTAATCAAAGATGATCCTAAAG TTATGTGGAAATATAAGAGATGCAGAGTAC
XbaI
B
Xba I (7454) Xba I (-6265)
Lmiiniin I I ,I I #t
I 1III IV V VI VII
I /'
// / !TGTTTGC
TATTGATTTCT AGTTTlT
FIG. 3. Sequence and schematic representation of the rat 7a-hydroxylase enhancer region. (A) The XbaI sites (at positions - 7454 and - 6265)
are boxed. Regions (FP I to FP VII) protected for DNase I digestion by nuclear extracts are underlined (for the bottom strand) and overlined (for
the top strand). Asterisks, positions of DNase I-hypersensitive cleavage sites. (B) Footprint sites (FP I, FP III, FP V, and'FP VI) which were
observed only with liver nuclear extracts (stippled ovals) and sites (FP II, FP IV, and FP VII) that were detected with extracts from both livers
and kidneys (open ovals) are depicted diagramatically on the XbaI (-7454)-to-XbaI'(-'6265) enhancer region. An 11-bp sequence closely related
to TTR-HNF-3 consensus [TATTGA(T/C)TTAfG] within the FP I protection site is shown. Homologies with TGT3-HNF-3 consensus
[T(G/A)TTTG(CtT)] located within FP V and FP VI are shown, and the nucleotides representing identical matches are boldfaced.
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LDL (ug/ml)
FIG. 4. LDL-mediated induction of CAT activity in H2.35 cells transfected with p7(xE-R7otCAT-5 and pAE-R7cxCAT-5. H2.35 cells were
transfected with p7aE-R7aCAT-5 (A) or pAE-R7aCAT-5 (B) and selected for G418 resistance as explained in Materials and Methods. For the
experiments, cells were seeded as explained in Materials and Methods, except that 60-mm-diameter dishes were used, and 4 x 105 or 106 cells were
seeded per plastic or collagen dish, respectively. The indicated concentrations of LDL were added at the time of medium change. For the
dedifferentiated cells lipoprotein-deficient serum was used instead of fetal calf serum when LDL was added. Average values for three experiments
done with two different transfections are shown, relative to the values of cells grown under dedifferentiating conditions, in the absence of LDL.
Bars, standard errors of the means.
DNase I footprinting analysis using liver nuclear extracts
revealed seven protection sites (data not shown). Exact loca-
tions of those footprint sites are shown on the enhancer
sequence (Fig. 3A). Footprints FP II, FP IV, and FP VII were
also detectable with kidney nuclear extract at least on one
strand, although the levels of protection were lower. On the
other hand, four regions corresponding to FP I, FP III, FP V,
and FP VI were protected only with liver extract on both
strands. Additionally, several hypersensitive sites (indicated by
asterisks on the DNA sequence in Fig. 3A) were also observed
near or within the protected sites.
Figure 3B shows a schematic summary of the nuclear protein
binding sites in the 7a-hydroxylase enhancer. The sequence
homologies between the sites protected by liver nuclear extract
but not by kidney extract (FP I, FP V, and FP VI) and known
liver-specific factor-binding sites are also illustrated. The FP
III site showed no homology with known binding sites. An
11-bp sequence closely related to the transthyretin-hepatocyte
nuclear factor 3 (TTR-HNF-3) consensus [TATTGA(T/
C)TTA/TG] (10) found within the FP I protection site is
shown. Similarly, homologies with TGT3-HNF-3 consensus
[T(G/A)T'TG(C/T)] (22) located within FP V and FP VI are
shown. The exact nature of the factor(s) that binds to those
sites is under investigation.
LDL up-regulates transcription of the 7a-hydroxylase prox-
imal promoter with either the mouse albumin enhancer or the
7a-hydroxylase enhancer. The protein binding sites located
within the 7a-hydroxylase enhancer suggested to us that per-
haps both enhancers are functionally similar. To study whether
the 7oa-hydroxylase enhancer could be substituted functionally
by the albumin enhancer, we constructed a hybrid plasmid,
pAE-R7aCAT-5. This plasmid contains the liver-specific en-
hancer from the mouse albumin gene described by Pinkert et
al. (43), encompassing the NheI-BamHI fragment extending
from - 10.4 to -8.5 kb, which also functions on the albumin
proximal promoter in H2.35 cells (56). We inserted this
fragment into pR7aCAT-5 just upstream of the 7ac-hydroxy-
lase promoter. This chimeric gene was transfected into H2.35
cells and cultured under either dedifferentiating or differenti-
ating conditions as described above.
The data in Fig. 4B demonstrate that the albumin enhancer
stimulated transcription of the 7ot-hydroxylase promoter (four-
to fivefold) in differentiated H2.35 cells compared with dedif-
ferentiated cells. This activation was similar to the one by the
7ct-hydroxylase enhancer in the chimeric gene p7aE-R7aCAT-5
(Fig. 2 and 4A). More importantly, when cells transfected with
either one of these chimeric genes were cultured in the presence
of increasing concentrations of human LDL, CAT activity rose
between 2- and 2.5-fold in differentiated cells. In dedifferenti-
ated cells lower activation, if any, was shown, suggesting that the
factor(s) involved in that process is probably expressed at higher
levels in differentiated H2.35 cells.
Incubation of those cell lines, H2.35 transfected with p7aE-
R7oaCAT-5 or pAE-R7aCAT-5 or H2.35 transfected with pAE-
R7aGal-3 (see Materials and Methods and below) with bile
acids showed only 2-fold regulation, at best, of the transcription
of the rat 7a-hydroxylase gene under all the conditions tested
(28), which is far from the 5- to 10-fold regulation in vivo.
Expression of albumin enhancer-7oL-hydroxylase promoter-
lacZ fusion gene in transgenic mice mimics the cholesterol and
bile acid-mediated regulation of the 7ox-hydroxylase gene. The
lack of quantitative bile acid-mediated regulation of the ex-
pression of 7a-hydroxylase promoter-CAT fusion genes in the
tissue culture system explained above could be due to the fact
that liver cells in culture often do not reproduce functions
observed in vivo (56), or, as it has been suggested, posttran-
scriptional control plays a major part in that regulation (52,
55). To address these questions, we decided to use transgenic
mice. Two fusion genes (Fig. 5) containing 1.6 kb of the
5'-flanking region of the rat 7a-hydroxylase gene were micro-
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+60 CAT SV40
_7aproe *
I *-TATAA 11\
SalI BamH I
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AE-R7axGAL-3 r EAlb.
Sph I Nhe I
-8500 -1633
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FIG. 5. Structures of the 7o-hydroxylase promoter constructs used to generate transgenic mice. A 1.6-kb fragment from the 5'-flanking region
of the rat 7ot-hydroxylase gene is denoted by a solid bar. Nucleotide positions - 1633 to +60 are numbered relative to the transcription initiation
site of the rat 7co-hydroxylase gene. The putative TATA box is shown. The - 10.4 to - 8.5 kb mouse albumin enhancer region is represented by
a stippled bar. The bacterial lacZ and CAT coding regions that were used as reporter genes and the SV40 t intron and polyadenylation site are
indicated. Restriction sites used for the construction of the corresponding plasmids and for the preparation of the DNAs for microinjection are
shown.
injected in mouse embryos and implanted in foster mothers.
R7otCAT-3 contains the 7a-hydroxylase 5'-flanking region in
front of the CAT gene. AE-R7utGal-3 contains the mouse
albumin enhancer in front of the 7ot-hydroxylase 5'-flanking
region and the lacZ gene. Table 1 is a summary of the mice
born as a result of those experiments. Of 47 mice screened for
the presence of R7oaCAT-3, 8 were positive, and they con-
tained one to five copies of the transgene integrated into their
genome. Expression experiments were performed with F1 mice
generated from each founder after the mice were fed a diet
containing 5% colestipol (a diet that increases 7ot-hydroxylase
mRNA [26]). We used nontransgenic mice from the same
litters as controls. No CAT activity was detected in any of those
mice.
Of 52 mice born as a result of the injection of AE-7otGal-3
DNA, 16 contained the transgene, and the number of inte-
grated copies ranged from 0.6 (presumably a mosaic mouse for
the transgene) to 7. Six of these transgenic founders were fed
a diet containing 5% colestipol, killed, and tested for expres-
sion of 3-galactosidase activity in liver extracts. Two of these
founders (FO-2 and FO-3) showed expression of the reporter
gene. The remaining founders were mated, and F1 mice were
tested for expression as above. One mouse line (line 1) showed
expression and was used for subsequent regulatory experi-
ments. The proportion of founder mice expressing the trans-
gene (1 in 5) can be considered average (42).
TABLE 1. Summary of experiments with transgenic micea
No. of No: Expressing No. of Reporter
pups tested positive (Fo) line genes/cellb activity'
R7oCAT-3 47 8 1-5 ND
AE-7oLGal-3 52 16 1 1 16.4
2 0.6 1.6
3 1 2.2
a Mouse embryos were microinjected with fusion genes R7aCAT-3 or AE-
7axGal-3. Pups born were tested for transgenicity by Southern blot analysis.
I-Galactosidase activity was measured in liver extracts as described in Materials
and Methods.
b Number of copies of the inserted DNA per genome, estimated from
Southern blots.
c In milliunits per milligram of protein. All animals were colestipol fed. For
founder 1, two mice from the F1 generation were tested. Founders 2 and 3 were
killed and tested. ND, not detectable.
To study whether the expression of the reporter gene in line
1 mice was restricted to the liver, as is the case for the
endogenous rat 7a-hydroxylase gene (26), protein extracts
were prepared from the livers, brains, heart, kidneys, and lungs
of animals fed a regular diet. As shown in Fig. 6, ,3-galactosi-
dase activity was clearly detectable in the liver, very low in the
heart, and undetectable in brain, kidney, and lung extracts.
Curiously, liver expression in males was fourfold higher than in
females (see Discussion).
The regulation of the expression of the albumin enhancer-
7ao-hydroxylase-4acZ transgene was examined by monitoring
changes in ,B-galactosidase activity in response to different
dietary manipulations that are known to control rat hepatic
7oa-hydroxylase. Mice were fed regular chow (normal diet) or
chow supplemented with colestipol, cholesterol, or bile acids
for 5 to 14 days, and both soluble protein extracts and total
RNA were prepared as described in Materials and Methods.
The results are shown in Fig. 7. Quantitatively equivalent levels
of regulation were observed for mice of both sexes, although
3-galactosidase activity was higher (three- to fourfold on
average) in males than in females under all tested dietary
4 -
1;
I
Po
.0
IT * Males
O Females
2
0 -
Liver Brain Heart Kidney Lung
FIG. 6. Expression of the 7a-hydroxylase-4acZ transgene in differ-
ent tissues. 1-Galactosidase activity was measured in liver, brain, heart,
kidney, and lung extracts as described in Materials and Methods.
Transgenic male or female mice from line 1 were kept on a regular
chow diet and killed between the 6th and 8th h of the dark period. The
data are means with standard errors of the means for five animals each.
-1633
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FIG. 7. Dietary regulation of albumin enhancer-7oa-hydroxylase-
lacZ fusion gene expression. Animals were fed the indicated diets as
described in Materials and Methods. 3-Galactosidase activity was
measured in liver extracts of 6- to 8-weeks-old male or female mice as
described in Materials and Methods. The data are means with standard
errors of the means for five to seven mice, expressed as relative
numbers normalized to the values for normally fed males (4 mU/mg of
protein).
conditions (see Discussion). Cholesterol feeding elevated
P-galactosidase activity 2.5-fold in males (P s 0.005) and
2-fold in females (P c 0.025), compared with mice fed a
normal diet. This correlates well with results in our tissue
culture system (Fig. 4). Similar induction was observed by
colestipol feeding of male (2.2-fold; P s 0.05) or female
(2.7-fold; P c 0.025) mice, compared with mice fed a normal
diet. Cholic acid feeding, on the other hand, reduced ,B-galac-
tosidase activity in both males (2.9-fold; P c 0.05) and females
(2.4-fold; P c 0.005). Chenodeoxycholic acid feeding also
reduced f-galactosidase activity in both males (4.3-fold; P c
0.025) and females. Most significantly, in males the level of
13-galactosidase activity in colestipol-fed mice (which corre-
sponds to the lowest level of bile acids in the liver) was 6.5-fold
(P c 0.005) higher than in cholic acid-fed mice and 9.5-fold (P
s 0.005) higher than in chenodeoxycholic acid-fed mice.
Likewise, female colestipol-fed mice showed 6.5-fold (P c
0.005) higher 3-galactosidase activity than cholic acid-fed mice
and 4.6-fold (P c 0.05) higher than chenodeoxycholic acid-fed
mice.
To confirm that those changes in 3-galactosidase activity
were a reflection of variations in the level of 3-galactosidase
mRNA and to determine whether expression of the endoge-
nous 7ot-hydroxylase mRNA was similarly regulated, we quan-
tified ,B-galactosidase mRNA and 7a-hydroxylase mRNA in
poly(A)+ RNA pools prepared from equal amounts of total
RNA from each mouse by slot blot analysis (Fig. 8). To
normalize the amount of loaded RNA, we also quantified
albumin mRNA. We used RNA from nontransgenic mice from
the same litters as a negative control. Three single-stranded
probes corresponding to the three mRNAs were used as
described in Materials and Methods.
As indicated in Fig. 8, ,B-galactosidase mRNA levels showed
a pattern of induction by cholesterol and colestipol, and of
suppression by cholic acid, similar to the enzymatic activity.
The level of 3-galactosidase mRNA in males was also higher
than that in females under all the dietary conditions. Regula-
tion of 7a-hydroxylase mRNA was very similar, with the
exception that no difference in the level of 7ot-hydroxylase
mRNA was observed between males and females under any
dietary condition. With these assay conditions, the 7ot-hydrox-
ylase mRNA in females fed colestipol showed a sixfold in-
crease with respect to normal females (Fig. 8A), in disagree-
ment with the regulation observed for the P-galactosidase
activity and mRNA. However, when the 7oa-hydroxylase
mRNA was quantified in the individual total RNA samples
rather than in the pooled poly(A)+ RNAs, a twofold induction
was observed (Fig. 8B), in agreement with the 3-galactosidase
activity and endogenous 7ot-hydroxylase mRNA.
DISCUSSION
It is common for liver-specific genes not to be expressed
and/or regulated in tissue culture systems in a manner similar
to that of the entire animal (56). Also, conditions such as
tissue-specific expression and cholesterol homeostasis require
whole animal models to study the complex interactions of
whole organ systems. In this study we have used two experi-
mental approaches to study the mechanisms by which choles-
terol and bile acids regulate expression of the 7oa-hydroxylase
gene. First, we used a mouse hepatocyte-derived cell line,
H2.35, that can be propagated in a dedifferentiated state and
then induced to the differentiated state at will (56). The
biological significance of this induction is emphasized by the
enhanced transcription of a number of liver-specific genes,
such as albumin and several liver-specific trans-acting factors
(25, 31, 56, 57), but not of genes encoding actin or rRNA (56).
Using this system, we have localized a liver-specific enhancer
located 7 kb upstream of the transcriptional initiation site of
the rat 7a-hydroxylase gene. We also showed that LDL
mediates transcriptional activation of chimeric genes, contain-
ing either the 7a-hydroxylase or the albumin enhancer in front
of the 7a-hydroxylase proximal promoter, to the same extent as
the in vivo cholesterol-mediated regulation of 7oa-hydroxylase
mRNA. However, in that tissue culture system bile acids only
partially (twofold, at best) regulated rat 7ot-hydroxylase pro-
moter activity. These limitations persuaded us to use trans-
genic mice to study the molecular mechanisms involved in the
regulation of 7ot-hydroxylase expression. Using that approach,
in this article we demonstrate that the promoter region of the
rat 7ce-hydroxylase gene mediates the regulation of its tran-
scription by bile acids and cholesterol. This regulation is
quantitatively similar to that of the endogenous mouse 7a-
hydroxylase gene and of the rat 7a-hydroxylase gene (7, 26,
53), indicating that posttranscriptional modification does not
play a major role, if any.
Several lines of evidence have led us to conclude the
existence of a liver-specific enhancer, 7 kb upstream from the
transcriptional initiation site, in the 7ot-hydroxylase gene. First,
cells transfected with pR7aCAT-9, the construct containing
the longest 7at-hydroxylase 5'-flanking region, has fourfold
higher CAT activity under dedifferentiating conditions than
cells transfected with pR7otCAT-8, which lacks the 1.2-kb Xba I
fragment from the far 5'-flanking region. All other 5' deletion
mutants studied showed levels of expression similar to that of
pR7aCAT-8 (Fig. 1). More importantly, when transfected
H2.35 cells were induced to differentiate to hepatocyte-like
cells, only pR7otCAT-9 showed higher expression (fourfold),
presumably due to an increase in the rate of transcription. This
was quantitatively similar to the induction of albumin tran-
scription in the same cells (56). Third, cells transfected with an
internally deleted mutant, p7caE-R7aCAT-5, that places the
putative enhancer in front of the 342 bp of proximal promoter
showed levels of increased expression upon differentiation that
were similar to that for pR7oaCAT-9 (Fig. 2). Quantification of
I
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FIG. 8. Dietary regulation of 7o-hydroxylase and P-galactosidase
mRNA levels in mouse liver. Poly(A)+ RNA was isolated from pooled
total RNA from livers of male and female mice fed the indicated diets
as described in Materials and Methods. Slot blots were hybridized withj 32P-labeled probes for 1-galactosidase [with 2.5 ,ug of poly(A)+ RNA],
n 7oz-hydroxylase [with 2.5 ,ug of poly(A)+ RNA or 10 ,ug of total RNA],
and albumin [with 0.5 p.g of poly(A)+ RNA] as a control. Nylon
membranes were exposed to X-ray film (A) for either 9 days (P-
galactosidase [gal]) or 24 h at - 70°C (7a-hydroxylase [7ox]) with
intensifying screens or 24 h at room temperature with no screen
(albumin). Radioactive bands were quantified (B) by using a Phosphor-
Imager (Molecular Dynamics) after a 24-h exposure and normalized
_
with respect to albumin mRNA. The value for colestipol-fed females
was obtained by averaging the individual total RNA samples rather
than the pooled poly(A)+ RNAs. The values are relative to those for
normally fed males. 1-Galactosidase mRNA from cholic acid-fed
female mice was undetectable. RNA from nontransgenic mice was
used as a negative control.
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mRNA by SI nuclease techniques confirmed that the induction
upon differentiation was due to an increase in the amount of
7ox-hydroxylase-CAT mRNA, and this mRNA was initiated at
the same place as the endogenous rat 7ox-hydroxylase tran-
scription initiation site (Fig. 2).
Another line of evidence that supports our finding of a
liver-specific enhancer in the rat 7ox-hydroxylase gene derived
from the DNA sequence and footprint analysis (Fig. 3 and data
not shown) of the enhancer region and from the DNA
sequence homologies found with the recognition sequences of
a liver-specific trans-acting factor HNF-3 (Fig. 3B). Four
regions within the 7ox-hydroxylase enhancer (FP I, III, V, and
VI) were protected only by liver nuclear extracts (Fig. 3). The
cluster of binding sites in the 7ot-hydroxylase enhancer resem-
bles a similar cluster in the mouse albumin enhancer (31) and
is a common characteristic of gene enhancers. Computer
analysis of a data base containing the recognition sequences
for liver-specific transcription factors revealed a 100% homol-
ogy with an octanucleotide found in FP VI (-6405 to -6440)
and the consensus binding site [T(G/A)TITG(C/T)T] for the
TGT3-HNF3 factor (Fig. 4B), which occurs at the eH site of
mouse albumin enhancer (25, 31) and other liver-specific genes
(17, 22, 34, 36, 50). Competition gel shift experiments also
suggested that the same or homologous factor binds to the eH
site of the albumin enhancer and to the FP VI site of the
7ot-hydroxylase enhancer (data not shown).
0 1 01 00 2 0 300
7t-hydroxylase mRNA/Albumin mRNA
(Relative Values)
The final evidence supporting the existence of a liver-specific
enhancer in the rat 7ox-hydroxylase gene comes from the
studies with the albumin enhancer. We have demonstrated that
the 7o-hydroxylase enhancer region can be functionally substi-
tuted by another liver-specific enhancer, the mouse albumin
enhancer (Fig. 4). This enhancer is essential for maximal
expression of the albumin promoter in differentiated H2.35
cells (56, 57) and in transgenic mice (43). Both basal activity
and induction of the expression upon cell differentiation from
chimeric genes that contain the 7oa-hydroxylase were equiva-
lent to those from the genes containing the mouse albumin
enhancer (Fig. 4). It has been suggested that the albumin
enhancer may require its own promoter, because it did not
function with the growth hormone promoter in transgenic mice
(43). Here, however, we demonstrate that the albumin en-
hancer can, in fact, activate a heterologous promoter both in
tissue culture cells (Fig. 4) and in transgenic mice (Fig. 5 to 8
and Table 1). This finding underlies the similarities between
both enhancers. First, the trans-acting factor(s) that binds to
both enhancers seems to be similar according to the sequence
homology and the gel shift competition experiments discussed
above. Second, the fact that the albumin enhancer can func-
tionally substitute the 7o-hydroxylase enhancer implies that
both enhancers are capable of interacting with the 7ao-hydrox-
ylase proximal promoter in vivo.
The 5'-flanking region of the human 7ot-hydroxylase gene
A
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has been isolated and functionally characterized with HepG2
cells as recipients (33). A liver-specific enhancer has been
localized at position -432 to - 220, although no cholesterol or
bile acid regulation has yet been shown to be mediated by this
5'-flanking region of the human 7a-hydroxylase gene. It is
interesting that the DNA sequence between -432 and -220,
which appears to confer cell specificity on the transcription of
the human 7a-hydroxylase gene, has only 51% homology with
the rat 7a-hydroxylase promoter and several of the relevant
regulatory elements found in the human promoter are missing
in the rat (33). Homologous elements (HNF-3 motifs) are
found in the rat enhancer located 7 kb upstream of the
transcriptional initiation site as described in this article (Fig.
3). It seems that perhaps evolution has placed that enhancer
closer to the proximal promoter in the human gene, although
it cannot be ruled out that the human gene contains another
enhancer at a position similar to that of the rat gene.
Expression of chimeric genes, containing the 7ot-hydroxylase
proximal promoter with either its own enhancer or the albumin
enhancer, is induced up to 2.5-fold in differentiated cells
incubated in the presence of LDL (Fig. 4). The concentrations
of LDL used (25 to 150 ,ug/ml) are well below the average
plasma LDL levels both in humans (approximately 1,200
pug/ml) and in other mammals (approximately 320 ,ug/ml) (19).
Considering that the concentration of LDL in the interstitial
fluid of humans is on the order of 10% of that in plasma, the
LDL concentrations that we used are well below what can be
considered physiological (19). In the absence of either one of
these enhancers, regulation could not be observed (28), sug-
gesting that interactions between the 7a-hydroxylase or albu-
min enhancers with the 7a-hydroxylase promoter are necessary
for LDL-mediated regulation of 7a-hydroxylase transcription.
This idea is in agreement with our observations that a common
element(s) may be present in both enhancers. An alternative
explanation could be that liver-specific activation, induced by
either enhancer, is essential for LDL-mediated induction of
7ot-hydroxylase transcription. This regulation in our tissue
culture system mimics the cholesterol-mediated induction of
7a-hydroxylase expression in rat liver (26, 30). Although we
cannot rule out that components of LDL other than choles-
terol might be the regulatory factor, the fact that the same level
of regulation has been observed in the entire animal upon
cholesterol feeding suggests that the effector is cholesterol.
25-Hydroxy cholesterol, the most potent sterol that down-
regulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase
and LDL receptor transcription in tissue culture cells (3, 4),
failed to show any effect on 7oa-hydroxylase gene expression in
our tissue culture system, suggesting that the active sterol that
up-regulates 7a-hydroxylase transcription is different from the
sterol that down-regulates those two other genes. This is in
agreement with the lack of significant homology between the
sterol regulatory elements in the promoter region of those
genes (3, 40) and the 7a-hydroxylase promoter, which suggests
that the trans-acting factor(s) involved in the cholesterol-
mediated induction of 7ax-hydroxylase transcription is different
from the factor(s) involved in the suppression of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase and LDL receptor tran-
scription. The LDL-mediated regulation was observed only in
differentiated H2.35 cells, suggesting that the factor(s) in-
volved in that process is expressed specifically in differentiated
hepatocytes.
Since we could not quantitatively reproduce the bile acid-
mediated regulation in our tissue culture system, we chose to
address that question by using transgenic mice. We introduced
two 7a-hydroxylase 5'-flanking region-reporter fusion genes
(Fig. 5) containing 1.6 kb of the 5'-flanking region and 59
nucleotides of the 5'-untranslated region of the rat 7a-hydrox-
ylase gene into the mouse genome. We used either the
bacterial CAT gene (R7aoCAT-3) or the lacZ gene (AE-
R7oxGal-3) as a reporter. AE-R7aGal-3 also contained the
mouse albumin enhancer upstream of the 7ot-hydroxylase
5'-flanking region. The mouse albumin enhancer was chosen
because it has been proven to be highly active in transgenic
mice (43) and it was at least as active as the 7a-hydroxylase
enhancer in tissue culture (Fig. 1, 2, and 4). The use of two
different reporter genes was circumstantial, and both genes
have been successfully used as reporters to study many differ-
ent promoters in transgenic mice (42, 44).
Several new insights can be deduced from our studies with
transgenic mice. First, transcription of the 7a-hydroxylase gene
seems to require the presence of a liver-specific enhancer in
vivo. Only transgenic mice carrying the AE-R7aGal-3 gene
expressed the reporter gene (Table 1), supporting our tissue
culture experiments which indicate that either the 7a-hydrox-
ylase enhancer or the albumin enhancer is necessary for
transcription of the 7oa-hydroxylase promoter (Fig. 1, 2, and 4).
Second, our results indicate that the cholesterol and bile
acid-mediated regulation of 7a-hydroxylase expression is tran-
scriptional and most, if not all, of the regulation can be
accounted for by that mechanism. This is deduced from a
direct comparison of the extent of regulation of ,B-galactosi-
dase activity (Fig. 7) and mRNA (Fig. 8) and endogenous
7a-hydroxylase mRNA levels, from both rats (7, 26, 53) and
mice (Fig. 8) under the different dietary conditions tested.
Thus, the regulation between colestipol-induced mice and
cholic- or chenodeoxycholic acid-suppressed mice is 5- to
9.5-fold for ,-galactosidase activity and 12-fold for 3-galacto-
sidase mRNA, compared with 13-fold for the endogenous
7a-hydroxylase mRNA.
A third insight derived from these studies is that the DNA
elements that mediate both the cholesterol regulation and the
bile acid regulation of 7at-hydroxylase transcription are located
in the 5'-flanking region of the gene. Since expression of the
AE-R7aGal-3 transgene, which contains the albumin en-
hancer, is regulated in the same manner as that of the
endogenous gene (Fig. 7 and 8), the enhancer region of the
7oa-hydroxylase gene, located 7 kb upstream of the transcrip-
tional initiation site, does not seem to be involved in the
regulation. Alternatively, similar interactions between the 7a-
hydroxylase or the albumin enhancer with the 7a-hydroxylase
promoter could be involved in the regulation. This is in
agreement with the data that we obtain with tissue culture for
the cholesterol-mediated regulation (Fig. 4). It should be
noted that albumin expression is not subject to cholesterol or
bile acid regulation (Fig. 8) (16), a finding which rules out the
possibility that the observed regulation is mediated by the
albumin enhancer. It is still possible that the regulation that we
have observed is due to some fortuitous combination of
sequences generated by the artificial albumin enhancer-7a-
hydroxylase chimeric promoter or to the site of chromosomal
integration. The fact that the regulation of the expression of
the reporter gene parallels, almost identically, the regulation of
the endogenous gene (Fig. 7 and 8) by cholesterol, colestipol,
and bile acids makes those possibilities very unlikely. Further-
more, preliminary experiments with a deleted version of the
albumin enhancer-7a-hydroxylase promoter construct in
transgenic mice (thus having different junction sequences)
show similar expression of the reporter gene, ruling out the
above-mentioned possibilities.
Surprisingly, the level of 3-galactosidase expression is be-
tween three- and fivefold higher in males than in females under
all the dietary conditions tested (Fig. 7 and 8), whereas the
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endogenous 7ox-hydroxylase gene is expressed at similar levels
in mice (Fig. 8) or even in a reverse manner in rats (53). There
are two possible explanations for this observation. First, it is
known that the place of chromosomal integration of the
transgene plays a role in the level of its expression (42).
Perhaps the transgene was integrated in a locus that is
transcribed at higher levels in males than in females. The other
possible explanation is that the transgene is more methylated
in female than in male mice and lower expression in females is
a reflection of that. This phenomenon has been previously
reported particularly in a C57BL/6 strain background. For
example, Engler et al. (14) reported that a transgene [pHRD,
containing target sequences for the V(D)J recombinase] was
highly methylated in 12 independent mouse lines when intro-
duced in a C57BL/6 strain background but became less meth-
ylated when bred into a DBAI2 background. Transgenes
inherited from the mother are generally more methylated;
however, this parental effect disappears following continued
breeding into the nonmethylating strain. Swain et al. (54) have
shown that a transgene containing both prokaryotic and eu-
karyotic DNA segments, none of which was derived from an
authentically imprinted gene, was expressed exclusively from
the paternal chromosome. The silent maternally inherited
copies were highly methylated. Strain C57BL/6 is the origin of
the mouse strain used in our experiments as an embryo donor
and for mating of founder mice (see Materials and Methods).
Experiments are in progress to assess these two possibilities.
Although there are several examples of genes whose tran-
scription is down-regulated by cholesterol (20) and the DNA
elements involved in that suppression have been defined (3, 40,
51), no information on DNA element(s) responsible for bile
acid-mediated regulation of gene transcription is available.
The availability of these expression systems provides a novel
and important step towards elucidating the molecular mecha-
nisms involved in the regulation of 7ox-hydroxylase transcrip-
tion by cholesterol and bile acids.
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